Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M80.1Revenue $M28.2Net Margin (%)0Z-Score6.4
Enterprise Value $M46.6EPS $-0.3Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yY
Price/Book2.810-y EBITDA Growth Rate %0Quick Ratio12.1Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio12.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-34.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-41.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M39.1ROI % (ttm)-107.2Gross Margin Increase y-yN

Gurus Latest Trades with BLRX

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BLRX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BLRX: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about BLRX :

    Quarterly/Annual Reports about BLRX:

      News about BLRX:

      Articles On GuruFocus.com
      Roth Capital Weighs In On 5 Biotech Stocks to Watch Apr 05 2015 


      More From Other Websites
      4 Stocks Under $10 Making Big Moves Apr 07 2015
      BIOLINERX LTD. Financials Mar 27 2015
      BioLineRx (BLRX) Looks Good: Stock Moves 9.1% Higher - Tale of the Tape Mar 25 2015
      BioLineRX stem cell leukaemia drug meets goals in early trial Mar 25 2015
      BioLineRx Reports Successful Top-Line Safety and Efficacy Results for Novel Stem Cell Mobilization... Mar 25 2015
      BioLineRx Reports Successful Top-Line Safety and Efficacy Results for Novel Stem Cell Mobilization... Mar 25 2015
      3 Stocks Under $10 Making Big Moves Higher Mar 24 2015
      BioLineRx Reports Year End 2014 Financial Results Mar 23 2015
      BioLineRx to Report Fourth Quarter and Year End 2014 Results on March 23, 2015 Mar 23 2015
      BioLineRx Reports Year End 2014 Financial Results Mar 23 2015
      BioLineRx to Report Fourth Quarter and Year End 2014 Results on March 23, 2015 Mar 17 2015
      BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares Mar 15 2015
      BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares Mar 11 2015
      BioLineRx’s Treatment for Type 1 Diabetes Effective in Preclinical Trials Mar 11 2015
      BioLineRx Prices $25 Million Underwritten Public Offering of its American Depositary Shares Mar 11 2015
      BioLineRx’s Treatment for Type 1 Diabetes Effective in Preclinical Trials Mar 11 2015
      BioLineRx to Present at the Annual Roth Conference in California Mar 06 2015
      BioLineRx to Present at the Annual Roth Conference in California Mar 06 2015
      BioLineRx Prices $25 Million Underwritten Public Offering of its American Depositary Shares Mar 06 2015
      BioLineRx Announces Underwritten Public Offering of its American Depositary Shares Mar 05 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK